MicroRNAs in Pancreatic Ductal Adenocarcinoma: New Diagnostic and Therapeutic Clues

Publisher： Karger

E-ISSN： 1424-3911|9|1-2|66-72

ISSN： 1424-3903

Source： Pancreatology, Vol.9, Iss.1-2, 2008-12, pp. : 66-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs as a New Potential Therapeutic Opportunity in Gastrointestinal Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 75-89

Karger

Access to resources Recommend Favorite

Therapeutic Targeting of microRNAs in Cancer: Future Perspectives

By  

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 382-388

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma

By  

Pancreatology, Vol. 11, Iss. 3, 2011-07 ,pp. : 343-350

Karger

Access to resources Recommend Favorite

Usefulness of exosome‐encapsulated microRNA‐451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 25, Iss. 2, 2018-02 ,pp. : 155-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNAs and Pancreatic Cancer: Current Research and Future Outlooks

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 305-307

Bentham Science Publishers

Access to resources Recommend Favorite